Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05130346
What this trial is testing

Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicObesity
Virginia Commonwealth University
Not applicableWithdrawnNCT03163810
What this trial is testing

See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Erchonia Corporation
Testing effectiveness (Phase 2)Ended earlyNCT04267393
What this trial is testing

Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Bristol-Myers Squibb 124
Not applicableEnrolling By InvitationNCT07564947
What this trial is testing

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Who this might be right for
MAFLDFatty LiverFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD+4 more
University of Agriculture, Peshawar 40
Large-scale testing (Phase 3)Study completedNCT05284448
What this trial is testing

Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Al-Azhar University 50
Testing effectiveness (Phase 2)Study completedNCT05338034
What this trial is testing

Phase 2a Study of HPG1860 in Subjects With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hepagene (Shanghai) Co., Ltd. 89
Not applicableEnded earlyNCT00878592
What this trial is testing

Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity

Who this might be right for
Post Liver Transplantation Weight GainPost Liver Transplantation ObesityNonalcoholic Steatohepatitis
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT01399645
What this trial is testing

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisType 2 Diabetes
Centre hospitalier de l'Université de Montréal (CHUM) 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Testing effectiveness (Phase 2)Ended earlyNCT03676231
What this trial is testing

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Second Genome 9
Not applicableStudy completedNCT02196831
What this trial is testing

Tesamorelin Effects on Liver Fat and Histology in HIV

Who this might be right for
Human Immunodeficiency Virus (HIV)Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
Massachusetts General Hospital 61
Testing effectiveness (Phase 2)Study completedNCT01919294
What this trial is testing

Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)

Who this might be right for
Nonalcoholic SteatohepatitisHypogonadism
Sheffield Teaching Hospitals NHS Foundation Trust 3
Very early researchNot Yet RecruitingNCT07198516
What this trial is testing

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Who this might be right for
NAFLDDiabete Type 2
Fujian Medical University Union Hospital 149
Not applicableStudy completedNCT01828528
What this trial is testing

Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Sheba Medical Center 26
Not applicableStudy completedNCT02513121
What this trial is testing

Dietary Treatment Study of Pediatric NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease
University of California, San Diego 40
Not applicableUnknownNCT02792634
What this trial is testing

Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery

Who this might be right for
Bariatric Surgery CandidateNonalcoholic SteatohepatitisObesity
RWTH Aachen University 200
Not applicableStudy completedNCT00940537
What this trial is testing

Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Liver Diseases
Washington University School of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT03656744
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Fatty Liver, NonalcoholicNAFLDNonalcoholic Fatty Liver Disease+3 more
HighTide Therapeutics (Hong Kong) Limited 101
Not applicableUnknownNCT04653311
What this trial is testing

Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Erasme University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02784444
What this trial is testing

Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Cirius Therapeutics, Inc. 392
Next Page